VOA 2分ニュース スクリプト 20/11/09

このニュースの解説(part 1)はナラボー・プレス社長の赤井田拓弥のブログに掲載されています。
解説(part 2)はこちらです。
解説(part 3)はこちらです。

「再生」を押すと出現するプレイヤーは, ↑↓ ボタンで読み上げスピードを調整できます。
音声が速すぎると感じる場合は ↓ ボタンを押してゆっくりにして聞いてみてください。

This is VOA News. Via remote, I'm Marissa Milton.

Pharmaceutical company Pfizer says late-stage testing on its potential COVID-19 vaccine indicates that it is more than 90% effective, exceeding expectations and bringing a rare piece of positive news to the fight against the coronavirus.

Pfizer made the announcement on Monday. Pfizer said its research showed the vaccine to be more than 90% effective in preventing the virus in participants without evidence of prior infection.

Dr. Anthony Fauci, the top infectious disease expert in the United States, said during a Monday press briefing that the results are [quote] “just extraordinary.” He said, “not many people expected it would be as high as that.” Fauci had previously said he was looking for a vaccine with 70% to 75% efficacy, and that even 50% was acceptable.

Pfizer’s chief executive cautioned that while this is a critical first step these results alone will not allow the company to apply for emergency authorization from the US Food and Drug Administration. He said more data on safety is needed.

US Health and Human Services Secretary Alex Azar said Monday it would take several weeks for US regulators to receive and independently review Pfizer's data before the government could potentially approve it.

From his Twitter account, US President Donald Trump noted the reported 90% efficiency calling it, in all caps, SUCH GREAT NEWS and added that the stock market was up big as a result.

President-elect Joe Biden praised the development in a statement on Monday. He warned, however, that the end of the battle against COVID-19 is still, in his words, “Months away.”

You can keep up on this story and all the other ones we’re covering at our website voanews.com. From Washington, you're listening to VOA News.